Rapport Therapeutics stockRAPP
Rapport Therapeutics trades at $23.72, 55.2% below its 52-week high (Aug 27, 2026). The price is below its 50- and 200-day averages, a downtrend. −21.8% year to date, −9.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 16, 2027.
Ratings, candles, signals and the screener for RAPP — after you log in
Open the terminalFrequently asked questions about Rapport Therapeutics
What is the Rapport Therapeutics stock price?
At the close on Nov 5, 2026: $23.72 (−8.52% on the day). 52-week high: $52.93 on Aug 27, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Rapport Therapeutics report earnings?
The next quarterly report is on Mar 16, 2027. Last quarter, earnings per share changed −18% year over year, revenue 0%.
Does Rapport Therapeutics pay dividends?
No, Rapport Therapeutics does not pay dividends.
Where does Rapport Therapeutics trade and how to buy it?
Ticker RAPP, exchange Nasdaq, listed since 2024. You can buy it through a broker with access to US exchanges.
Should I buy Rapport Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RAPP are in the terminal after you log in.